In a co-published analysis on World Trademark Review, Sunstein’s London K Lundstrum explains how The Trademark Modernization Act makes registration and protection faster and more cost-efficient for pharmaceutical brands.

The Trademark Modernization Act (TMA) opened the door for individuals and business to use new methods to clear away unused registered trademarks from the federal register, as well as expedite the registration process.

The TMA made changes within three main areas: ex parte proceedings, prosecution and litigation. These changes will benefit companies, including pharmaceutical companies, to register their marks quickly and in a more cost effective way. It also increases the value of litigation. This article gives a brief overview of the new tools established by the TMA.

Read more here.